Relmada Therapeutics
RLMD
#9903
Rank
$11.45 M
Marketcap
$0.38
Share price
4.60%
Change (1 day)
-88.43%
Change (1 year)

Relmada Therapeutics (RLMD) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $8.09 Million USD

According to Relmada Therapeutics's latest financial reports the company's total liabilities are $8.09 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Relmada Therapeutics - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31$12.46 M-17.21%
2021-12-31$15.06 M19.5%
2020-12-31$12.6 M
2019-06-30$2.6 M-69.56%
2018-06-30$8.56 M521.89%
2017-06-30$1.37 M-57%
2016-06-30$3.2 M-79.45%
2015-06-30$15.58 M-42.01%
2014-06-30$26.87 M
2013-08-31$0.03 M381.22%
2012-08-31$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$0.38 B 4,642.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.44 B 17,802.37%๐Ÿ‡บ๐Ÿ‡ธ USA